CorVita Health is pleased to offer a comprehensive clinical genetics consultation for management of sudden cardiac death and cardiac electronic implantable device clinical decision making.
Specific areas of interest include the following clinical diseases, syndromes and conditions:
- Cardiomyopathies- Dilated, Hypertrophic, Mixed Conditions, Amyloidosis, Arrhythmogenic Ventricular Cardiomyopathies (ARVC), Long QT Syndromes, Brugada Syndromes, Short QT syndromes, Marfan Syndromes, Mitral Valve Prolapse, Catecholamine Polymorphic Ventricular Tachycardia (CPVT), Mitochondrial disorders,
- Arrhythmic Conditions- congenital heart block, Sarcoidosis, TTN (TITIN DISORDERS), LMNA disorders, repetitive monomorphic ventricular tachycardia, idiopathic ventricular fibrillation and atrial fibrillation.
- Familial Hyperlipidemia
- Cardiac tumors
Phased Approach to Consultation:
Phase I: Phenotypic (known abnormality) presentation of index patient.
Phase II: Focused Genetic Testing
Phase III: Testing result applied to the clinical condition(s).
Phase IV: Appropriate counseling of the patient based on abnormal genetic finding with clinical
management.
Phase V: Family assessments and testing recommendations.
Phase VI: Continuing outpatient clinical care.